Streptococcal A vaccine - Active Biotech

Drug Profile

Streptococcal A vaccine - Active Biotech

Latest Information Update: 01 Jul 2002

Price : $50

At a glance

  • Originator Active Biotech
  • Class Streptococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Suspended Streptococcal infections

Most Recent Events

  • 01 Jul 2002 Streptococcus A vaccine is due to be licensed out to a collaboration partner during 2002
  • 14 Dec 2000 Actinova has been closed down
  • 14 Dec 2000 Suspended-Preclinical for Streptococcal infections in Sweden (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top